A reappraisal of atypical absence seizures in children and adults: therapeutic implications

References

• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–530.
   PubMed Web of Science ®Google Scholar
• Brigo F, Trinka E, Lattanzi S, et al. A brief history of typical absence seizures - Petit mal revisited. Epilepsy Behav. 2018;80:346–353.
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. Typical absence seizures and related epileptic syndromes: assessment of current state and directions for future research. Epilepsia. 2008;49:2131–2139.
   PubMed Web of Science ®Google Scholar
• Sadleir LG, Farrell K, Smith S, et al. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology. 2006;67(3):413–418.
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. Epileptic Seizures and their Classification. In: Panayiotopoulos CP, editor. A clinical guide to epileptic syndromes and their treatment. Springer Healthcare Ltd; 2010.
   Google Scholar
• Epilepsydiagnosis.org, international league against epilepsy, atypical absence seizures. 2019. Available from https://www.epilepsydiagnosis.org/seizure/absence-atypical-overview.html.
   Google Scholar
• Tatum IVWO, Farrell K. Atypical absence, myoclonic, tonic, and atonic seizures. In: Wyllie E, Gupta A, Lachhwani DK, editors. The treatment of epilepsy: principles & practice. Lippincott Williams & Wilkins; 2006.
   Google Scholar
• Avanzini G, de Curtis M, Marescaux C, et al. Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves. J Neural Transm Suppl. 1992;35:85–95.
   PubMedGoogle Scholar
• Avanzini G, Manganotti P, Meletti S, et al. The system epilepsies: a pathophysiological hypothesis. Epilepsia. 2012;53(5):771–778.
   PubMed Web of Science ®Google Scholar
• Wang X, Stewart L, Cortez MA, et al. The circuitry of atypical absence seizures in GABA(B)R1a transgenic mice. Pharmacol Biochem Behav. 2009;94(1):124–130.
   PubMed Web of Science ®Google Scholar
• Velazquez JL, Huo JZ, Dominguez LG, et al. Typical versus atypical absence seizures: network mechanisms of the spread of paroxysms. Epilepsia. 2007;48(8):1585.
   PubMed Web of Science ®Google Scholar
• Onat FY, van Luijtelaar G, Nehlig A, et al. The involvement of limbic structures in typical and atypical absence epilepsy. Epilepsy Res. 2013;103(2–3):111–123.
   PubMed Web of Science ®Google Scholar
• Chan KF, Jia Z, Murphy PA, et al. Learning and memory impairment in rats with chronic atypical absence seizures. Exp Neurol. 2004;190(2):328–336.
   PubMed Web of Science ®Google Scholar
• Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–685.
   PubMed Web of Science ®Google Scholar
• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521.
   PubMed Web of Science ®Google Scholar
• Vlaskamp DRM, Shaw BJ, Burgess R, et al. SYNGAP1 encephalopathy: a distinctive generalized developmental and epileptic encephalopathy. Neurology. 2019;92(2):e96–e107.
   PubMed Web of Science ®Google Scholar
• De Vivo DC, Trifiletti RR, Jacobson RI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325(10):703–709.
   PubMed Web of Science ®Google Scholar
• Suls A, Mullen SA, Weber YG, et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol. 2009;66:415–419.
   PubMed Web of Science ®Google Scholar
• Mullen SA, Suls A, De Jonghe P. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology. 2010;75(5):432–440.
   PubMed Web of Science ®Google Scholar
• Agostinelli S, Traverso M, Accorsi P, et al. Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution. Eur J Neurol. 2013;20(5):856–859.
   PubMed Web of Science ®Google Scholar
• Wang D, Chu PC, Yang CN, et al. Development of a novel class of glucose transporter inhibitors. J Med Chem. 2012;55(8):3827–3836.
   PubMed Web of Science ®Google Scholar
• Oguni H, Ito Y, Otani Y, et al. Questionnaire survey on the current status of ketogenic diet therapy in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) in Japan. Eur J Paediatr Neurol. 2018;22(3):482–487.
   PubMed Web of Science ®Google Scholar
• Shinawi M, Schaaf CP, Bhatt SS, et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet. 2009;41(12):1269–1271.
   PubMed Web of Science ®Google Scholar
• Coppola A, Bagnasco I, Traverso M, et al. Different electroclinical picture of generalized epilepsy in two families with 15q13.3 microdeletion. Epilepsia. 2013;54(5):e69–73.
   PubMed Web of Science ®Google Scholar
• Archer JS, Warren AE, Jackson GD, et al. .Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy. Front Neurol. 2014;30;5:225.
   Web of Science ®Google Scholar
• Verrotti A, Striano P, Iapadre G, et al. The pharmacological management of Lennox-Gastaut syndrome and critical literature review. Seizure. 2018;63:17–25.
   PubMed Web of Science ®Google Scholar
• Vrielynck P. Current and emerging treatments for absence seizures in young patients. Neuropsychiatr Dis Treat. 2013;9:963–975.
   PubMed Web of Science ®Google Scholar
• Brigo F, Striano P, Balagura G, et al. Emerging drugs for the treatment of Dravet syndrome. Expert Opin Emerg Drugs. 2018 Nov 27. DOI:10.1080/14728214.2018.1552937.
   PubMedGoogle Scholar
• Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8(1):82–93.
   PubMed Web of Science ®Google Scholar
• Tsuda Y, Oguni H, Sakauchi M, et al. An electroclinical study of absence seizures in Dravet syndrome. Epilepsy Res. 2013;103(1):88–96.
   PubMed Web of Science ®Google Scholar
• Belcastro V, D‘Egidio C, Striano P, et al. Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res. 2013;107(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Cross JH, Auvin S, Falip M, et al. Expert Opinion on the management of Lennox-Gastaut Syndrome: treatment algorithms and practical considerations. Front Neurol. 2017;8:505. eCollection 2017. .
   PubMed Web of Science ®Google Scholar
• Brigo F, Igwe SC, Lattanzi S. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2019;2:CD003032. .
   PubMedGoogle Scholar
• Canadian Clobazam Cooperative Group. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia. 1991;32(3):407–416.
   PubMed Web of Science ®Google Scholar
• Ng YT, Conry JA, Drummond R, et al. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011;77(15):1473–1481.
   PubMed Web of Science ®Google Scholar
• Timmings PL, Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol. 1992;32(6):305–307.
   PubMed Web of Science ®Google Scholar
• Donaldson JA, Glauser TA, Olberding LS. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Epilepsia. 1997;38(1):68–73.
   PubMed Web of Science ®Google Scholar
• Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337(25):1807–1812.
   PubMed Web of Science ®Google Scholar
• De Los Reyes EC, Sharp GB, Williams JP, et al. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol. 2004;30(4):254–256.
   PubMed Web of Science ®Google Scholar
• Shaaya EA, Grocott OR, Laing O, et al. Seizure treatment in Angelman syndrome: a case series from the Angelman Syndrome Clinic at Massachusetts General Hospital. Epilepsy Behav. 2016;60:138–141.
   PubMed Web of Science ®Google Scholar
• Striano P, Sofia V, Capovilla G, et al. A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). Epilepsia. 2008;49(3):425–430.
   PubMed Web of Science ®Google Scholar
• Farwell JR, Anderson GD, Kerr BM, et al. Stiripentol in atypical absence seizures in children: an open trial. Epilepsia. 1993;34(2):305–311.
   PubMed Web of Science ®Google Scholar
• Glauser T, Kluger G, Sachdeo R, et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950–1958.
   PubMed Web of Science ®Google Scholar
• Sachdeo R, Kramer LD, Rosenberg A, et al. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol. 1992;32(3):386–392.
   PubMed Web of Science ®Google Scholar
• Jensen PK. Felbamate in the treatment of Lennox-Gastaut syndrome. Epilepsia. 1994;35(Suppl 5):S54–57.
   PubMedGoogle Scholar
• European Medicines Agency. 2017 Felbamate: List of nationally authorised medicinal products. Available from: https://www.ema.europa.eu/en/documents/psusa/felbamate-list-nationally-authorised-medicinal-products-psusa/00010155/201609.
   Google Scholar
• Laux LC, Bebin EM, Checketts D, et al. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Res. 2019;154:13–20.
   PubMed Web of Science ®Google Scholar
• Snead HLC. Exacerbation of seizures in children by carbamazepine. N Engl J Med. 1985;313(15):916–921.
   PubMed Web of Science ®Google Scholar
• Vossler DG. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. Neurology. 1996;46(3):852–853.
   PubMed Web of Science ®Google Scholar
• Nehlig A, Dufour F, Klinger M, et al. ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from Strasbourg. J Neurochem. 2009;109(Suppl 1):207–213.
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. from the commission on classification and terminology of the international league against epilepsy. Epilepsia. 1981;22(4):489–501.
   PubMed Web of Science ®Google Scholar
• Bare MA, Glauser TA, Strawsburg RH. Need for electroencephalogram video confirmation of atypical absence seizures in children with Lennox- Gastaut syndrome. J Child Neurol. 1998;13:498–500.
   PubMed Web of Science ®Google Scholar
• Avoli M. A brief history on the oscillating roles of thalamus and cortex in absence seizures. Epilepsia. 2012;53:779–789.
   PubMed Web of Science ®Google Scholar
• Snead OC 3rd. Basic mechanisms of generalized absence seizures. Ann Neurol. 1995;37:146–157.
   PubMed Web of Science ®Google Scholar